- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Atopic dermatitis
- Meeting Date: March 2020
- Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB)
- Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)
Dupilumab – March 2020
Dupilumab: Injection 300 mg in 2 ml single use pre-filled syringe; Dupixent®
Last updated
3 July 2020